In contrast, the expression levels of MPO, ELA2, ARG1, and ICAM1 remained unchanged in all treatment groups, indicating that rhGDF15 and rhTNF-α have selective effects on tumor-promoting cytokine expression. This evidence concerns the gene ARG1 and neoplasm.